Master of Microbial Biotechnology Candidate
Communication and Teamwork
Explore my portfolio.
Breast cancer is the most common cancer diagnosis for women in the United States. According to the National Institute of Health (NIH), it is estimated that there will be 268,000 new cases of breast cancer and 42,000 breast cancer-related deaths in 2019. Mammography is the gold standard in breast cancer detection. However, screening mammography is associated with some harms including overdiagnosis and overtreatment, false-negative results, and false-positive results.
As a result, artificial intelligence (AI) and machine learning have emerged to enhance current mammography technologies and breast cancer screening. The development of AI algorithms has helped improve cancer detection efficacy and accuracy by increasing sensitivity and specificity and decreasing reading time
T-cells genetically engineered to express the chimeric antigen receptor (CAR) is emerging as a revolutionary immunotherapy for hematologic cancers. In particular, the anti-CD19 CAR T-cell therapy has been successful at inducing complete remission in patients with refractory or relapsed acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL).
​